| scholarly article | Q13442814 |
| P2093 | author name string | E J Gane | |
| P2860 | cites work | Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome | Q43236443 |
| Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality | Q43752482 | ||
| Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C. | Q44839519 | ||
| Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. | Q45126678 | ||
| Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. | Q45699015 | ||
| Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States | Q45740183 | ||
| Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation. | Q45948454 | ||
| Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. | Q46727424 | ||
| Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation. | Q46738356 | ||
| A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients | Q46781368 | ||
| Conversion from tacrolimus to cyclosporine in liver transplanted patients with diabetes mellitus | Q46959043 | ||
| Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients. | Q46984189 | ||
| Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. | Q50571808 | ||
| Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study. | Q51482450 | ||
| A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation | Q54022204 | ||
| Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus | Q58376682 | ||
| Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3 | Q27477554 | ||
| New onset diabetes mellitus after liver transplantation and hepatitis C virus infection: meta-analysis of clinical studies | Q33407635 | ||
| Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial | Q34155167 | ||
| Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma | Q34544988 | ||
| Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance | Q34993507 | ||
| Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. | Q35016133 | ||
| Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis. | Q36694182 | ||
| Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up. | Q36696738 | ||
| Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis | Q37097794 | ||
| Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes | Q37179559 | ||
| Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin | Q37197379 | ||
| Extrahepatic hepatitis C virus after transplantation: diabetes and renal dysfunction | Q37282568 | ||
| The natural history of recurrent hepatitis C and what influences this | Q37282591 | ||
| Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression | Q39935106 | ||
| Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population | Q40495823 | ||
| Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes | Q40622941 | ||
| HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors | Q40998392 | ||
| Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. | Q42456523 | ||
| Cyclosporine versus tacrolimus treated liver transplant recipients with chronic hepatitis C: outcomes analysis of the UNOS/OPTN database | Q42600645 | ||
| Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients. | Q42822350 | ||
| Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection | Q42984502 | ||
| Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation | Q42985745 | ||
| The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study | Q42991465 | ||
| Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C | Q43000127 | ||
| The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. | Q43000675 | ||
| Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin. | Q43001526 | ||
| 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus | Q43031760 | ||
| Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation | Q43034823 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 531-538 | |
| P577 | publication date | 2011-11-28 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences | |
| P478 | volume | 12 |
| Q26859205 | "Weighing the risk": Obesity and outcomes following liver transplantation |
| Q52733190 | Association between ADIPOQ gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation. |
| Q42208034 | Association between E23K variant in KCNJ11 gene and new-onset diabetes after liver transplantation |
| Q41650484 | CC genotype at rs12979860 of IL28B is associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis. |
| Q33810193 | Care of the liver transplant patient |
| Q45299361 | Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease |
| Q33875539 | Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients |
| Q40242723 | Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients. |
| Q58704499 | Liver transplantation and hepatitis C |
| Q36587253 | Living-donor liver transplantation and hepatitis C |
| Q35924990 | Metabolic syndrome after a liver transplantation in an Asian population. |
| Q87755723 | New-onset diabetes and hypertension as complications of liver transplantation |
| Q39438721 | New-onset diabetes mellitus developing in Asian adult living donor liver transplant recipients: a single-center experience |
| Q38089859 | Pediatric post-transplant metabolic syndrome: new clouds on the horizon |
| Q35137567 | Polymorphism of Transcription Factor-7-Like 2 (TCF7L2) Gene and New-Onset Diabetes after Liver Transplantation |
| Q51333234 | Predisposing factors of diminished survival in simultaneous liver/kidney transplantation. |
| Q30870794 | The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients |
| Q42214820 | The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. |
| Q50550145 | Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers. |
| Q36292616 | Use of Hepatitis C-Positive Donor Livers in Liver Transplantation |
Search more.